Clinical guideline released for the treatment of COPD exacerbations The European Respiratory Society and the American Thoracic Society have released a guideline for the treatment of patients with COPD ...

The SPIROMICS study found considerable year-to-year heterogeneity in acute chronic obstructive pulmonary disease (COPD) exacerbation patterns over 3 years of follow-up. Similarly, a Danish nationwide ...

The European Respiratory Society and the American Thoracic Society have conducted a comprehensive review of evidence of managing exacerbations of chronic obstructive pulmonary disease in order to ...

Short- vs. Longer-Duration Corticosteroid Tx for COPD Exacerbations Currently, COPD guidelines recommend that patients with acute exacerbations be treated with systemic corticosteroids for 7-14 days, ...

An additional 5 years of aromatase inhibitor therapy can improve breast cancer outcomes. Researchers found that doxycycline plus prednisone did not prolong the time between exacerbations in patients ...

Gabapentinoid use in patients with chronic obstructive pulmonary disease (COPD) was associated with a higher risk for severe exacerbations, a population-based cohort study from Canada indicated. Among ...

A multicentre study was performed in a cohort of patients with moderate or severe COPD enrolled under a 2-year observational protocol in Spain to compare moxifloxacin with other antimicrobials. The ...

Patients with acute COPD exacerbations are seen frequently in the emergency department (ED). Acute exacerbations are associated with significant morbidity, mortality and health care expenditures.

Chronic obstructive pulmonary disease (COPD) is a long-term lung disease affecting at least 15 million American adults. It’s also the fourth leading cause of disease-attributed death. This makes ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — In patients with moderate to severe COPD without an established indication for beta-blocker use, ...

Researchers identified 5 distinct clusters for disease exacerbation that went beyond disease labels for both asthma and chronic obstructive pulmonary disease (COPD). When examining common factors for ...